Blueprint Investment Partners’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,551
Closed -$200K 144
2024
Q1
$200K Sell
1,551
-313
-17% -$37.8K 0.04% 135
2023
Q4
$213K Buy
+1,864
New +$186K 0.06% 128
2023
Q3
Sell
-4,041
Closed -$455K 160
2023
Q2
$455K Buy
4,041
+1,998
+98% +$211K 0.16% 89
2023
Q1
$214K Sell
2,043
-1,852
-48% -$193K 0.05% 218
2022
Q4
$431K Buy
+3,895
New +$408K 0.09% 134
2022
Q1
Sell
-1,930
Closed -$231K 260
2021
Q4
$231K Sell
1,930
-656
-25% -$81.4K 0.06% 176
2021
Q3
$320K Buy
2,586
+848
+49% +$109K 0.16% 94
2021
Q2
$208K Sell
1,738
-273
-14% -$31.2K 0.17% 71
2021
Q1
$212K Buy
+2,011
New +$204K 0.17% 63

Other funds holding XYL

Blueprint Investment Partners's XYL Position: Q2 2024 in Review

Blueprint Investment Partners sold out of Xylem (XYL) in Q2 2024, closing a stake of 1,551 shares — an estimated $200K sold.

Blueprint Investment Partners first reported a position in XYL in Q1 2021 and held it in 9 quarters. The position peaked at $455K in Q2 2023. 1,033 funds tracked by Wall St. Rank hold XYL as of Q2 2024.

  • Blueprint Investment Partners reported no remaining Xylem position as of Q2 2024 after selling out during the quarter.
  • Blueprint Investment Partners sold 1,551 Xylem shares in Q2 2024, an estimated $200K.
  • Blueprint Investment Partners first reported a position in Xylem in Q1 2021 and held it in 9 quarters.
  • Blueprint Investment Partners's Xylem position peaked at $455K in Q2 2023.
  • 1,033 funds tracked by Wall St. Rank held Xylem as of Q2 2024.

Based on Blueprint Investment Partners's 13F filing for Q2 2024, filed 14 Aug 2024.